Ed Hannigan

Suggest Changes
Learn More
PURPOSE To evaluate the anti-tumor activity and adverse events of capecitabine in advanced, persistent or recurrent squamous cell carcinoma of the cervix, and to explore biomarkers with the potential(More)
  • 1